Skip to content
TriangleGet started
← Peripheral T-Cell Non-Hodgkin Lymphoma

HEALTH PROFESSIONAL · SOURCE READING

Treatment Options for Adult T-Cell Leukemia/Lymphoma

Source: Peripheral T-Cell Non-Hodgkin Lymphoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 13, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

Context: Treatment of Adult T-Cell Leukemia/Lymphoma

Treatment options for ATL include:

Biological and targeted therapies.

Source links and citations

Biological and targeted therapies.

Mogamulizumab.

Source links and citations

Biological and targeted therapies.

Brentuximab vedotin.

Source links and citations

Biological and targeted therapies.

Lenalidomide.

Source links and citations

Biological and targeted therapies.

Valemetostat.

Source links and citations

Biological and targeted therapies.

Zidovudine and interferon alfa.

Source links and citations

Cytotoxic chemotherapy and allogeneic stem cell transplant (SCT).

Source links and citations

Continue within this section

Biological and targeted therapies →Cytotoxic chemotherapy and allogeneic SCT →

Preserved source evidence · Independent clinical review pending · Not medical advice